Schizophrenia

« Back to Glossary Index

Schizophrenia, classified as a psychotic disorder, is a severe and chronic brain disorder that affects how a person thinks, feels, and behaves, causing them to interpret reality abnormally or lose touch with it. It’s an extremely disruptive, lifelong condition. Research suggests schizophrenia stems from a complex interaction of genetic predisposition, brain chemistry (neurotransmitters like dopamine and glutamate), brain structure abnormalities, and environmental factors (stress, exposure to specific viruses, or substance use like cannabis). A combination of treatments — medication, psychotherapy, and coordinated specialty care (CSC) — is highly effective in managing symptoms. Early diagnosis and consistent treatment significantly improve the prognosis and quality of life. Schizophrenia typically begins late teens–early 30s and symptoms are grouped into three main categories:

POSITIVE SYMPTOMS: Unusual perceptions and beliefs “added” to reality.

Hallucinations are not-real sensations (hearing voices, seeing things, feeling sensations on the skin), with hearing voices the most common
Delusions are strong, fixed but false beliefs despite contrary evidence (believing one is being followed, is very famous, or is mind-controlled)
Disorganized thinking and speech, resulting in jumbled or incoherent speech, shifting rapidly between unrelated topics, or making up words

NEGATIVE SYMPTOMS: Absence or reduction of normal emotions and behaviors.

Reduced ability to function normally (neglecting personal hygiene)
Lack of emotion or expression (flat affect)
Loss of interest or pleasure in everyday activities (anhedonia)
Social withdrawal and lack of motivation

COGNITIVE SYMPTOMS: Difficulties with

Attention, concentration, memory
Processing information to make decisions

RENAMING SCHIZOPHRENIA: Due to stigma, discrimination, and public ignorance, international patient advocacy groups and mental health professionals want to see a name change—a complex process requiring broad consensus that hasn’t yet been reached. Opponents argue it won’t solve these root problems, claiming educational campaigns and better treatments are more effective uses of resources. Alternative names already proposed, focused on being more descriptive and less stigmatizing, include: altered perception syndrome, psychosis spectrum syndrome, neuro-emotional integration disorder, integration disorder, and attunement disorder. Four main arguments for renaming:

Stigmatized and associated in popular culture and the media with violence, unpredictability, and incurability. Stigma leads to discrimination and causes many to delay treatment or hide their diagnosis, which negatively affects care and quality of life.
Scientific inaccuracy, though term itself, derived from Greek, incorrectly suggests “split personality,” leading to confusion with dissociative identity disorder. Current science sees it as a complex syndrome or spectrum of brain disorders.
Stakeholder preference from surveys in various countries, including the U.S., show a majority of people with lived experience, their families, and clinicians favor a name change.
Positive international precedent: Several Asian countries have already successfully changed its name, resulting in a reduction in stigma, improved communication between doctors and patients, and increased willingness to seek treatment. Japan changed it to integration disorder in 2002, and SouthKorea to attunement disorder in 2012.